Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ARQ-621 well tolerated to date in phase I study

May 7, 2010

Phase II results show TZP-101 efficacy in severe gastroparesis

May 6, 2010

Cinacalcet allows lower doses of calcitriol and phosphate for X-linked hypophosphatemia

May 6, 2010

Novel anti-CD27 antibody displays preclinical potential in cancer therapy

May 6, 2010

Stable disease noted in non-small cell lung cancer patients given HyperAcute-Lung cancer vaccine

May 6, 2010

Thymosin beta4 safe in phase II corneal wound-healing study

May 6, 2010

Combined GM-CSF and agatolimod arm melanoma sentinel lymph nodes against metastasis

May 6, 2010

Pan-CDK inhibitor BAY-1000394 exhibits favorable pharmacologic profile in preclinical evaluation

May 5, 2010

LiGluR gene therapy reinstates visual responses in inherited blindness models

May 5, 2010

Antioxidant activity of dextromethorphan may be beneficial in retinitis pigmentosa

May 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...